Guanshu Liu1,2, Yah-el Har-el2, Chris Long3, Assaf A. Gilad2,4, George Sgouros2, Jeff W.M. Bulte2,4, Peter C.M. van Zijl1,2, Michael T. McMahon1,2
1F.M. Kirby Center, Kennedy Krieger Institute, Baltimore, MD, USA; 2Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; 3Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD; 4Institute for Cellular Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
In order to facilitate the noninvasive detection of lymphatic delivery of anticancer drugs, we developed a new MRI-visible liposome system based on labeling with the diamagnetic Chemical Exchange Saturation Transfer (DIACEST) agent L-arginine. Using B0-corrected CEST-MRI, the accumulation of liposome in the popliteal lymph node could be visualized in vivo in mice (n = 3). To validate the approach, liposomes were simultaneously labeled with a fluorescent chromophore, the fluorescence of which correlated with the CEST intensity. This new DIACEST liposome system allows direct visualization of drug delivery to the lymph nodes without using paramagnetic material.
Keywords